6 Kidney Cancer Journal
T A B L E O F C O N T E N T S
Remembering Professor Martin Gore,
1951–2019
Tributes pour in, honoring him as ‘force of nature,’
brilliant clinician
lthough most of the 4500 or so attendees at this
year’s GU ASCO meeting may not have been aware,
the death of Professor Martin Gore cast a long
shadow over the proceedings for those of us who knew
this brilliant clinician and outstanding human being.
Dr Gore, 67, one of the UK’s leading oncologists, died in
January after experiencing total organ failure following a
yellow fever vaccination, an extremely rare complication.
A report in the Journal of Travel Medicine found that
between 2007 and 2013, there were just under four
cases of serious adverse effects from the vaccine per 100,000 doses. This
increased to 6.5 per 100,000 for those aged between 60 and 69, and 10.3
per 100,000 for those aged 70 and above. The vaccination is recommended
for anyone visiting Sub-Saharan
Africa, South and Central
America, and the Caribbean.
Dr Gore, who inspired generations
of physicians, was a
professor at the Institute of
Cancer Research and former
Medical Director of the Royal
Marsden Hospital, London.
Prof Mel Greaves, from The
Institute of Cancer Research,
said: “Martin was something
of a force of nature, very energetic,
clear thinking and compassionate.”
In the following recollection, Professor Tim Eisen highlights
his memories of Dr Gore.
Robert A. Figlin, MD
Editor-in-Chief
Editorial Mission
The purpose of Kidney Cancer Journal is to serve as a compre-
hensive resource of information for physicians regarding
advances in the diagnosis and treatment of renal cell carcinoma.
Content of the journal focuses on the impact of translational
research in oncology and urology and also provides a forum for
cancer patient advocacy. Kidney Cancer Journal is circulated to
medical oncologists, hematologist-oncologists, and urologists.
Editor-in-Chief
Robert A. Figlin, MD, FACP
Steven Spielberg Family Chair in Hematology Oncology
Professor of Medicine and Biomedical Sciences
Director, Division of Hematology Oncology
Deputy Director, Samuel Oschin Comprehensive
Cancer Institute
Cedars-Sinai Medical Center
Los Angeles, California
Medical Advisory Board
Michael B. Atkins, MD
Deputy Director
Lombardi Comprehensive Cancer Center
Professor of Oncology and Medicine,
Georgetown University Medical Center
Washington, DC
Robert J. Motzer, MD
Attending Physician
Memorial Sloan-Kettering
Cancer Center
New York, NY
Brian Rini, MD
Professor of Medicine
Cleveland Clinic Lerner College of
Medicine of Case Western
Reserve University
Cleveland, Ohio
Christopher G. Wood, MD, FACS
Douglas E. Johnson, MD Professorship
Professor & Deputy Chairman
Department of Urology
M.D. Anderson Cancer Center
Houston, Texas
Nurse Advisory Board
Nancy Moldawer, RN, MSN
Nursing Director
Cedars-Sinai Medical Center
Samuel Oschin Comprehensive Cancer Institute
Los Angeles, California
Laura Wood, RN, MSN, OCN
Renal Cancer Research Coordinator
Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio
Patient Advocate
Gretchen Vaughan
Chief Executive Officer
Kidney Cancer Association
Publishing Staff
Stu Chapman, Executive Editor
Jenny Chapman, Director, Business Development
Michael McClain, Design Director
Director of Advertising
Susan Hirschhaut
(847) 476-0588
susan@datamedica.org
Business and Administration Office
333 E. 75th Street, Suite 5D
New York, NY 10021
Editorial Offices
Genitourinary Publishing
333 E. 75th Street, Suite 5D
New York, NY 10021
Tel: (516) 356-5006
Copyright © 2019 Genitourinary Publishing. All rights reserved.
None of the contents may be reproduced in any form without
the permission of the publisher.
About the Cover
This image illustrates an example of multi-modal collection for a
radical nephrectomy specimen and how it could be integrated
into a biospecimen banking system. The points suggest how a surgical
sample could be processed for inclusion in multiple studies
such as a RCC tissue microarray, multi-region proteomic sampling,
larger core biopsies for patient-derived xeno-grafts, or for bulk tissue
acquisition for organoids and other larger-scale models and
analyses. (Courtesy of John Leppert, MD)
8 Journal Club
9 Medical Intelligence
10 Supporting Kidney Cancer Research: Lessons Learned Establishing
The Stanford Kidney Cancer Biospecimen Repository
18 GU ASCO 2019: Encapsulating Highlights Through Lens of a
Key Opinion Leader With Insights, Forecasts and Take-Home Messages
22 A Novel Combination Therapy Takes an Innovative Approach by
Targeting a Key Metabolic Pathway to Block RCC Growth
E D I TO R ’ S M E M O
(continued on page 7)
Robert A. Figlin, MD
Professor Martin Gore
A
link